X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
TEVA PHARMA
Dec-13
JUBILANT LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1872,921-   
Low Rs652,537-   
Sales per share (Unadj.) Rs364.31,676.4-  
Earnings per share (Unadj.) Rs6.8104.7-  
Cash flow per share (Unadj.) Rs24.5240.2-  
Dividends per share (Unadj.) Rs3.0091.67-  
Dividend yield (eoy) %2.43.4 70.9%  
Book value per share (Unadj.) Rs164.91,862.1-  
Shares outstanding (eoy) m159.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 21.2%   
Avg P/E ratio x18.426.1 70.6%  
P/CF ratio (eoy) x5.111.4 45.3%  
Price / Book Value ratio x0.81.5 52.1%  
Dividend payout %43.887.5 50.1%   
Avg Mkt Cap Rs m20,0612,314,379 0.9%   
No. of employees `0006.244.9 13.8%   
Total wages/salary Rs m11,0520-   
Avg. sales/employee Rs Th9,383.031,629.2 29.7%   
Avg. wages/employee Rs Th1,786.90-   
Avg. net profit/employee Rs Th176.31,975.9 8.9%   
INCOME DATA
Net Sales Rs m58,0341,421,574 4.1%  
Other income Rs m1910-   
Total revenues Rs m58,2241,421,574 4.1%   
Gross profit Rs m5,786389,299 1.5%  
Depreciation Rs m2,812114,907 2.4%   
Interest Rs m3,23727,922 11.6%   
Profit before tax Rs m-72246,470 -0.0%   
Minority Interest Rs m-2861,120 -25.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-161,794 -1.3%   
Tax Rs m696-3,009 -23.1%   
Profit after tax Rs m1,09088,805 1.2%  
Gross profit margin %10.027.4 36.4%  
Effective tax rate %-965.9-1.2 79,112.4%   
Net profit margin %1.96.2 30.1%  
BALANCE SHEET DATA
Current assets Rs m29,280960,126 3.0%   
Current liabilities Rs m38,912837,311 4.6%   
Net working cap to sales %-16.68.6 -192.1%  
Current ratio x0.81.1 65.6%  
Inventory Days Days8491 92.9%  
Debtors Days Days5196 52.8%  
Net fixed assets Rs m55,712464,317 12.0%   
Share capital Rs m1553,499 4.4%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,2651,579,099 1.7%   
Long term debt Rs m17,169726,882 2.4%   
Total assets Rs m88,6063,248,752 2.7%  
Interest coverage x1.09.8 9.9%   
Debt to equity ratio x0.70.5 142.0%  
Sales to assets ratio x0.70.4 149.7%   
Return on assets %4.93.6 135.9%  
Return on equity %4.25.6 73.8%  
Return on capital %11.64.9 234.6%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,026226,525 3.5%  
From Investments Rs m-1,744-80,267 2.2%  
From Financial Activity Rs m-4,447-271,732 1.6%  
Net Cashflow Rs m1,834-125,474 -1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.98 Rs / USD

Compare JUBILANT LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare JUBILANT LIFE SCIENCES With: DIVIS LABORATORIES  ALEMBIC PHARMA  UNICHEM LAB  CIPLA  GSK PHARMA  



Today's Market

Sensex Extends Gains; Vedanta & Yes Bank Lead the Rally(12:30 pm)

Stock markets in India are trading higher taking cues from their Asian peers, which rebounded today following a strong lead in Wall Street.

Related Views On News

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 17, 2018 02:51 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - SUVEN LIFE COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS